Exchange: OTC·Updated 03:55 PM EDT

ELTP News

News
all
press releases
ELTP vs. DERM: Which Specialty Pharmaceutical Stock Is the Better Buy?
Elite Pharmaceuticals and Journey Medical follow different growth paths, but which looks more compelling now? Let's dive in.
Zacks
More News
Elite Pharmaceuticals Stock Plunges Post Q1 Earnings, Revenues Fall Y/Y
ELTP's first-quarter fiscal 2027 revenues decline as generic competition and lower pricing offset higher volumes, while pipeline development remains a growth focus.
Zacks
Possible Generic Drug Tariffs and 2 Microcaps
Generic drug tariffs could impact ELTP and CPIX.
Zacks
ELTP vs. CPIX: Which Pharma Stock Is the Better Buy Right Now?
Elite Pharmaceuticals and Cumberland Pharmaceuticals follow different growth paths, but which looks more compelling now? Let's dive in.
Zacks
Elite Pharmaceuticals Stock Slips Despite Record Fiscal 2026 Earnings
ELTP delivers record fiscal 2026 results, with stronger profits, improved cash and pipeline progress supporting its expanding generics platform.
Zacks
The Zacks Analyst Blog Highlights GE Aerospace, Shell, McKesson, Elite Pharmaceuticals and Geospace Technologies
GE, SHEL and MCK lead Zacks picks, driven by strong demand, cash flow growth and strategic expansion despite cost and market risks.
Zacks
Top Stock Reports for GE Aerospace, Shell & McKesson
GE Aerospace gains on strong engine demand and defense tailwinds, while Shell and McKesson navigate mixed performance and strategic shifts.
Zacks
Elite Pharmaceuticals Stock Dips Post Q3 Earnings Despite Revenue Jump
ELTP reports surging revenue and profit in third-quarter fiscal 2026, but margin pressure and M&A ambitions steal the spotlight.
Zacks
ELTP Stock Declines Despite Solid Q2 Earnings and Revenue Performance
Elite Pharmaceuticals delivers record second-quarter fiscal 2026 earnings as lisdexamfetamine sales surged, though margins faced competitive pressure.
Zacks
The Zacks Analyst Blog Highlights Berkshire Hathaway, Toyota Motor, McDonald's, Elite Pharmaceuticals and BK Technologies
Zacks highlights Berkshire Hathaway, Toyota, McDonald's, Elite Pharma and BK Technologies as diverse plays with unique growth catalysts and risks.
Zacks

Advertisement|Remove ads.